{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:15:15Z","timestamp":1788999315015,"version":"build-2803163510"},"reference-count":170,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>MUC proteins have great significance as prognostic and diagnostic markers as well as a potential target for therapeutic interventions in most cancers of glandular epithelial origin. These are high molecular weight glycosylated proteins located in the epithelial lining of several tissues and ducts. Mucins belong to a heterogeneous group of large O-glycoproteins that can be either secreted or membrane-bound. Glycosylation, a post-translational modification affects the biophysical, functional and biochemical properties and provides structural complexity for these proteins. Aberrant expression and glycosylation of mucins contribute to tumour survival and proliferation in many cancers, which in turn activates numerous signalling pathways such as NF-kB, ER&amp;#945;, HIF, MAPK, p53, c-Src, Wnt and JAK-STAT, etc. This subsequently induces cancer cell growth, proliferation and metastasis. The present review mainly demonstrates the functional aspects of MUC glycoproteins along with its unique signalling mechanism and role of aberrant glycosylation in cancer progression and therapeutics. The importance of MUC proteins and its subtypes in a wide spectrum of cancers including but not limited to breast cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, primary liver cancer, pancreatic cancer, prostate cancer and ovarian cancer has been exemplified with significance in targeting the same. Several patents associated with the MUC proteins in the field of cancer therapy are also emphasized in the current review.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1568009620666201116113334","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T05:50:22Z","timestamp":1605592222000},"page":"132-152","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy"],"prefix":"10.2174","volume":"21","author":[{"given":"Chameli","family":"Ratan","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Ponekkara P. O., Kochi, Kerala 682041,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Cicily K. D","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Ponekkara P. O., Kochi, Kerala 682041,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagyalakshmi","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Ponekkara P. O., Kochi, Kerala 682041,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekshmi. R.","family":"Nath","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Ponekkara P. O., Kochi, Kerala 682041,India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"Hollingsworth M.A.","year":"2004","unstructured":"Hollingsworth M.A.; Swanson B.J.; Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004,4(1),45-60","journal-title":"Nat Rev Cancer"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.critrevonc.2017.12.006","volume":"122","author":"Dhanisha S.S.","year":"2018","unstructured":"Dhanisha S.S.; Guruvayoorappan C.; Drishya S.; Abeesh P.; Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets. Crit Rev Oncol Hematol 2018,122,98-122","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nrc2761","volume":"9","author":"Kufe D.W.","year":"2009","unstructured":"Kufe D.W.; Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009,9(12),874-885","journal-title":"Nat Rev Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1158\/1078-0432.CCR-16-0862","volume":"23","author":"Rao C.V.","year":"2017","unstructured":"Rao C.V.; Janakiram N.B.; Mohammed A.; Molecular pathways: mucins and drug delivery in cancer. Clin Cancer Res 2017,23(6),1373-1378","journal-title":"Clin Cancer Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejca.2008.10.008","volume":"45","author":"Kalra A.V.","year":"2009","unstructured":"Kalra A.V.; Campbell R.B.; Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours. Eur J Cancer 2009,45(1),164-173","journal-title":"Eur J Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nature13535","volume":"511","author":"Paszek M.J.","year":"2014","unstructured":"Paszek M.J.; DuFort C.C.; Rossier O.; Bainer R.; Mouw J.K.; Godula K.; Hudak J.E.; Lakins J.N.; Wijekoon A.C.; Cassereau L.; Rubashkin M.G.; Magbanua M.J.; Thorn K.S.; Davidson M.W.; Rugo H.S.; Park J.W.; Hammer D.A.; Giannone G.; Bertozzi C.R.; Weaver V.M.; The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature 2014,511(7509),319-325","journal-title":"Nature"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbcan.2014.04.008","volume":"1846","author":"Jonckheere N.","year":"2014","unstructured":"Jonckheere N.; Skrypek N.; Van Seuningen I.; Mucins and tumor resistance to chemotherapeutic drugs. Biochim Biophys Acta 2014,1846(1),142-151","journal-title":"Biochim Biophys Acta"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1432-1033.1993.tb17575.x","volume":"211","author":"Klein A.","year":"1993","unstructured":"Klein A.; Carnoy C.; Lamblin G.; Roussel P.; van Kuik J.A.; Vliegenthart J.F.; Vliegenthart J.F.G.; Isolation and structural characterization of novel sialylated oligosaccharide-alditols from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis. Eur J Biochem 1993,211(3),491-500","journal-title":"Eur J Biochem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1183\/09031936.94.07091678","volume":"7","author":"Rogers D.F.","year":"1994","unstructured":"Rogers D.F.; Airway goblet cells: responsive and adaptable front- line defenders. Eur Respir J 1994,7(9),1690-1706","journal-title":"Eur Respir J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fchem.2019.00710","volume":"7","author":"Pinz&#xF3;n Mart&#xED;n S.","year":"2019","unstructured":"Pinz&#xF3;n Mart&#xED;n S.; Seeberger P.H.; Var&#xF3;n Silva D.; mucins and pathogenic mucin-like molecules are immunomodulators during infection and targets for diagnostics and vaccines. Front Chem Pinz&#xF3;n2019,7,710","journal-title":"Front Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000234225","volume":"82","author":"Snyder J.D.","year":"1987","unstructured":"Snyder J.D.; Walker W.A.; Structure and function of intestinal mucin: developmental aspects. Int Arch Allergy Appl Immunol 1987,82(3-4),351-356","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.09.023","volume":"124","author":"Bansil R.","year":"2018","unstructured":"Bansil R.; Turner B.S.; The biology of mucus: Composition, synthesis and organization. Adv Drug Deliv Rev 2018,124,3-15","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-cellbio-100617-062818","volume":"34","author":"Wagner C.E.","year":"2018","unstructured":"Wagner C.E.; Wheeler K.M.; Ribbeck K.; Mucins and their role in shaping the functions of mucus barriers. Annu Rev Cell Dev Biol 2018,34,189-215","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1042\/BST20170402","volume":"46","author":"Ridley C.","year":"2018","unstructured":"Ridley C.; Thornton D.J.; Mucins: the frontline defence of the lung. Biochem Soc Trans 2018,46(5),1099-1106","journal-title":"Biochem Soc Trans"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"31791","DOI":"10.1038\/srep31791","volume":"6","author":"Xu D.","year":"2016","unstructured":"Xu D.; Pavlidis P.; Thamadilok S.; Redwood E.; Fox S.; Blekhman R.; Ruhl S.; Gokcumen O.; Recent evolution of the salivary mucin MUC7. Sci Rep 2016,6,31791","journal-title":"Sci Rep"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000453594","volume":"9","author":"van Putten J.P.M.","year":"2017","unstructured":"van Putten J.P.M.; Strijbis K.; Transmembrane mucins: signaling receptors at the intersection of inflammation and cancer. J Innate Immun 2017,9(3),281-299","journal-title":"J Innate Immun"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrgastro.2013.35","volume":"10","author":"Johansson M.E.","year":"2013","unstructured":"Johansson M.E.; Sj&#xF6;vall H.; Hansson G.C.; The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013,10(6),352-361","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.biochi.2012.11.00510.1016\/j.biochi.2012.11.005","volume":"95","author":"Jonckheere N.","year":"2013","unstructured":"Jonckheere N.; Skrypek N.; Fr&#xE9;nois F.; Van Seuningen I.; Membrane-bound mucin modular domains: from structure to function. Biochimie 2013,95(6),1077-1086","journal-title":"Biochimie"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.sbi.2011.08.007","volume":"21","author":"Cullen P.J.","year":"2011","unstructured":"Cullen P.J.; Post-translational regulation of signaling mucins. Curr Opin Struct Biol 2011,21(5),590-596","journal-title":"Curr Opin Struct Biol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gut.44.3.387","volume":"44","author":"Van Klinken B.J.","year":"1999","unstructured":"Van Klinken B.J.; Van der Wal J.W.; Einerhand A.W.; B&#xFC;ller H.A.; Dekker J.; Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 1999,44(3),387-393","journal-title":"Gut"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbcan.2015.08.003","volume":"1856","author":"Chugh S.","year":"2015","unstructured":"Chugh S.; Gnanapragassam V.S.; Jain M.; Rachagani S.; Ponnusamy M.P.; Batra S.K.; Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets. Biochim Biophys Acta 2015,1856(2),211-225","journal-title":"Biochim Biophys Acta"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"a005199","DOI":"10.1101\/cshperspect.a005199","volume":"3","author":"Stanley P.","year":"2011","unstructured":"Stanley P.; Golgi glycosylation. Cold Spring Harb Perspect Biol 2011,3(4),a005199","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/10409239891204198","volume":"33","author":"Van den Steen P.","year":"1998","unstructured":"Van den Steen P.; Rudd P.M.; Dwek R.A.; Opdenakker G.; Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol 1998,33(3),151-208","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ref=24","author":"Stanley P.","year":"2009","unstructured":"Stanley P.; Schachter H.; Taniguchi N.; N-Glycans. Essentials of GlycobiologyVarki, A; Cummings, RD; Esko, JD 2nd edition 2009 https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1917\/","journal-title":"Essentials of GlycobiologyVarki, A; Cummings, RD; Esko, JD 2nd edition"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1146\/annurev.bi.54.070185.003215","volume":"54","author":"Kornfeld R.","year":"1985","unstructured":"Kornfeld R.; Kornfeld S.; Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985,54,631-664","journal-title":"Annu Rev Biochem"},{"key":"ref=26","author":"Brockhausen I.","year":"2009","unstructured":"Brockhausen I.; Schachter H.; Stanley P.; O-GalNAc Glycans. Essentials of Glycobiology Varki, A; Cummings, RD; Esko, JD 2nd edition 2009 https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1896\/?report=classic","journal-title":"Essentials of Glycobiology Varki, A; Cummings, RD; Esko, JD 2nd edition"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00010","volume":"86","author":"Rose M.C.","year":"2006","unstructured":"Rose M.C.; Voynow J.A.; Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006,86(1),245-278","journal-title":"Physiol Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1126\/science.1099250","volume":"305","author":"Kawakubo M.","year":"2004","unstructured":"Kawakubo M.; Ito Y.; Okimura Y.; Kobayashi M.; Sakura K.; Kasama S.; Fukuda M.N.; Fukuda M.; Katsuyama T.; Nakayama J.; Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 2004,305(5686),1003-1006","journal-title":"Science"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrmicro2538","volume":"9","author":"McGuckin M.A.","year":"2011","unstructured":"McGuckin M.A.; Lind&#xE9;n S.K.; Sutton P.; Florin T.H.; Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011,9(4),265-278","journal-title":"Nat Rev Microbiol"},{"key":"ref=30","first-page":"119","volume":"12","author":"Smirnova M.G.","year":"2001","unstructured":"Smirnova M.G.; Kiselev S.L.; Birchall J.P.; Pearson J.P.; Up-regulation of mucin secretion in HT29-MTX cells by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-6. Eur Cytokine Netw 2001,12(1),119-125","journal-title":"Eur Cytokine Netw"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1440-1711.2003.t01-1-01163.x","volume":"81","author":"Iwashita J.","year":"2003","unstructured":"Iwashita J.; Sato Y.; Sugaya H.; Takahashi N.; Sasaki H.; Abe T.; mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol 2003,81(4),275-282","journal-title":"Immunol Cell Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1172\/JCI111875","volume":"75","author":"Hayes D.F.","year":"1985","unstructured":"Hayes D.F.; Sekine H.; Ohno T.; Abe M.; Keefe K.; Kufe D.W.; Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest 1985,75(5),1671-1678","journal-title":"J Clin Invest"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/1097-0142(20010601)91:11<1973:aid-cncr1222>3.0.co;2-a","volume":"91","author":"Rahn J.J.","year":"2001","unstructured":"Rahn J.J.; Dabbagh L.; Pasdar M.; Hugh J.C.; The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer 2001,91(11),1973-1982","journal-title":"Cancer"},{"key":"ref=34","first-page":"4033","volume":"7","author":"Andrianifahanana M.","year":"2001","unstructured":"Andrianifahanana M.; Moniaux N.; Schmied B.M.; Ringel J.; Friess H.; Hollingsworth M.A.; B&#xFC;chler M.W.; Aubert J.P.; Batra S.K.; Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 2001,7(12),4033-4040","journal-title":"Clin Cancer Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1309\/7Y7N-M1WM-R0YK-M2VA","volume":"117","author":"Swartz M.J.","year":"2002","unstructured":"Swartz M.J.; Batra S.K.; Varshney G.C.; Hollingsworth M.A.; Yeo C.J.; Cameron J.L.; Wilentz R.E.; Hruban R.H.; Argani P.; MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 2002,117(5),791-796","journal-title":"Am J Clin Pathol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1309\/cev30be088cbdqd9","volume":"126","author":"Jhala N.","year":"2006","unstructured":"Jhala N.; Jhala D.; Vickers S.M.; Eltoum I.; Batra S.K.; Manne U.; Eloubeidi M.; Jones J.J.; Grizzle W.E.; Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol 2006,126(4),572-579","journal-title":"Am J Clin Pathol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/hep.20031","volume":"39","author":"Shibahara H.","year":"2004","unstructured":"Shibahara H.; Tamada S.; Higashi M.; Goto M.; Batra S.K.; Hollingsworth M.A.; Imai K.; Yonezawa S.; MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 2004,39(1),220-229","journal-title":"Hepatology"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1158\/1078-0432.CCR-05-2814","volume":"12","author":"Tamada S.","year":"2006","unstructured":"Tamada S.; Shibahara H.; Higashi M.; Goto M.; Batra S.K.; Imai K.; Yonezawa S.; MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res 2006,12(14 Pt 1),4257-4264","journal-title":"Clin Cancer Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/modpathol.3800646","volume":"19","author":"Chauhan S.C.","year":"2006","unstructured":"Chauhan S.C.; Singh A.P.; Ruiz F.; Johansson S.L.; Jain M.; Smith L.M.; Moniaux N.; Batra S.K.; Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 2006,19(10),1386-1394","journal-title":"Mod Pathol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"Bast R.C.","year":"2009","unstructured":"Bast R.C.; Hennessy B.; Mills G.B.; The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 2009,9(6),415-428","journal-title":"Nat Rev Cancer"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2019.12.019","volume":"472","author":"Si P.","year":"2020","unstructured":"Si P.; Shi J.; Zhang P.; Wang C.; Chen H.; Mi X.; Chu W.; Zhai B.; Li W.; MUC-1 recognition-based activated drug nanoplatform improves doxorubicin chemotherapy in breast cancer. Cancer Lett 2020,472,165-174","journal-title":"Cancer Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3892\/ol.2020.11762","volume":"20","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Tang L.; Gao N.; Diao Y.; Zhong J.; Deng Y.; Wang Z.; Jin G.; Wang X.; Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects. Oncol Lett 2020,20(3),2369-2377","journal-title":"Oncol Lett"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev.physiol.70.113006.100702","volume":"70","author":"Thornton D.J.","year":"2008","unstructured":"Thornton D.J.; Rousseau K.; McGuckin M.A.; Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol 2008,70,459-486","journal-title":"Annu Rev Physiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.acr.2014.11.002","volume":"126","author":"Kudelka M.R.","year":"2015","unstructured":"Kudelka M.R.; Ju T.; Heimburg-Molinaro J.; Cummings R.D.; Simple sugars to complex disease- mucin-type O-glycans in cancer. Adv Cancer Res 2015,126,53-135","journal-title":"Adv Cancer Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fendo.2013.00129","volume":"4","author":"Adler K.B.","year":"2013","unstructured":"Adler K.B.; Tuvim M.J.; Dickey B.F.; Regulated mucin secretion from airway epithelial cells. Front Endocrinol (Lausanne) 2013,4,129","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.18632\/oncotarget.2370","volume":"5","author":"Joshi S.","year":"2014","unstructured":"Joshi S.; Kumar S.; Choudhury A.; Ponnusamy M.P.; Batra S.K.; Altered Mucins (MUC) trafficking in benign and malignant conditions. Oncotarget 2014,5(17),7272-7284","journal-title":"Oncotarget"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1021\/pr4010184","volume":"13","author":"Pan S.","year":"2014","unstructured":"Pan S.; Chen R.; Tamura Y.; Crispin D.A.; Lai L.A.; May D.H.; McIntosh M.W.; Goodlett D.R.; Brentnall T.A.; Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. J Proteome Res 2014,13(3),1293-1306","journal-title":"J Proteome Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/biom2040435","volume":"2","author":"Julien S.","year":"2012","unstructured":"Julien S.; Videira P.A.; Delannoy P.; Sialyl-tn in cancer: (how) did we miss the target? Biomolecules 2012,2(4),435-466","journal-title":"Biomolecules"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0304-4165(99)00170-1","volume":"1473","author":"Brockhausen I.","year":"1999","unstructured":"Brockhausen I.; Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999,1473(1),67-95","journal-title":"Biochim Biophys Acta"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"10231","DOI":"10.1073\/pnas.172380699","volume":"99","author":"Hakomori S.","year":"2002","unstructured":"Hakomori S.; Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 2002,99(16),10231-10233","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10719-008-9186-9","volume":"26","author":"Robbe-Masselot C.","year":"2009","unstructured":"Robbe-Masselot C.; Maes E.; Rousset M.; Michalski J.C.; Capon C.; Glycosylation of human fetal mucins: a similar repertoire of O-glycans along the intestinal tract. Glycoconj J 2009,26(4),397-413","journal-title":"Glycoconj J"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fonc.2014.00028","volume":"4","author":"H&#xE4;uselmann I.","year":"2014","unstructured":"H&#xE4;uselmann I.; Borsig L.; Altered tumor-cell glycosylation promotes metastasis. Front Oncol 2014,4,28","journal-title":"Front Oncol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0925-4439(99)00055-1","volume":"1455","author":"Taylor-Papadimitriou J.","year":"1999","unstructured":"Taylor-Papadimitriou J.; Burchell J.; Miles D.W.; Dalziel M.; MUC1 and cancer. Biochim Biophys Acta 1999,1455(2-3),301-313","journal-title":"Biochim Biophys Acta"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e72413","DOI":"10.1371\/journal.pone.0072413","volume":"8","author":"Madsen C.B.","year":"2013","unstructured":"Madsen C.B.; Lavrsen K.; Steentoft C.; Vester-Christensen M.B.; Clausen H.; Wandall H.H.; Pedersen A.E.; Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing. PLoS One 2013,8(9),e72413","journal-title":"PLoS One"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1600-0854.2010.01061.x","volume":"11","author":"Havrylov S.","year":"2010","unstructured":"Havrylov S.; Redowicz M.J.; Buchman V.L.; Emerging roles of Ruk\/CIN85 in vesicle-mediated transport, adhesion, migration and malignancy. Traffic 2010,11(6),721-731","journal-title":"Traffic"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.18632\/oncotarget.1265","volume":"4","author":"Cascio S.","year":"2013","unstructured":"Cascio S.; Farkas A.M.; Hughey R.P.; Finn O.J.; Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration. Oncotarget 2013,4(10),1686-1697","journal-title":"Oncotarget"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","volume":"36","author":"Mereiter S.","year":"2019","unstructured":"Mereiter S.; Balma&#xF1;a M.; Campos D.; Gomes J.; Reis C.A.; Glycosylation in the era of cancer-targeted therapy: where are we heading? Cancer Cell 2019,36(1),6-16","journal-title":"Cancer Cell"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.18632\/oncotarget.22377","volume":"9","author":"Very N.","year":"2017","unstructured":"Very N.; Lefebvre T.; El Yazidi-Belkoura I.; Drug resistance related to aberrant glycosylation in colorectal cancer. Oncotarget 2017,9(1),1380-1402","journal-title":"Oncotarget"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/cells9020446","volume":"9","author":"Gupta R.","year":"2020","unstructured":"Gupta R.; Leon F.; Rauth S.; Batra S.K.; Ponnusamy M.P.; A systematic review on the implications of o-linked glycan branching and truncating enzymes on cancer progression and metastasis. Cells 2020,9(2),446","journal-title":"Cells"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/glycob\/cww131","volume":"27","author":"Movahedin M.","year":"2017","unstructured":"Movahedin M.; Brooks T.M.; Supekar N.T.; Gokanapudi N.; Boons G.J.; Brooks C.L.; Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen. Glycobiology 2017,27(7),677-687","journal-title":"Glycobiology"},{"key":"ref=61","first-page":"76","volume":"61","author":"Vercoutter-Edouart A.S.","year":"2001","unstructured":"Vercoutter-Edouart A.S.; Lemoine J.; Le Bourhis X.; Louis H.; Boilly B.; Nurcombe V.; R&#xE9;villion F.; Peyrat J.P.; Hondermarck H.; Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells. Cancer Res 2001,61(1),76-80","journal-title":"Cancer Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D.","year":"2011","unstructured":"Hanahan D.; Weinberg R.A.; Hallmarks of cancer: the next generation. Cell 2011,144(5),646-674","journal-title":"Cell"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5493\/wjem.v2.i5.86","volume":"2","author":"Gam L-H.","year":"2012","unstructured":"Gam L-H.; Breast cancer and protein biomarkers. World J Exp Med 2012,2(5),86-91","journal-title":"World J Exp Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1470-2045(01)00560-5","volume":"2","author":"Srinivas P.R.","year":"2001","unstructured":"Srinivas P.R.; Kramer B.S.; Srivastava S.; Trends in biomarker research for cancer detection. Lancet Oncol 2001,2(11),698-704","journal-title":"Lancet Oncol"},{"key":"ref=65","first-page":"129","volume":"132","author":"Bhatt A.N.","year":"2010","unstructured":"Bhatt A.N.; Mathur R.; Farooque A.; Verma A.; Dwarakanath B.S.; Cancer biomarkers - current perspectives. Indian J Med Res 2010,132,129-149","journal-title":"Indian J Med Res"},{"key":"ref=66","first-page":"1160","volume":"48","author":"Srinivas P.R.","year":"2002","unstructured":"Srinivas P.R.; Verma M.; Zhao Y.; Srivastava S.; Proteomics for cancer biomarker discovery. Clin Chem 2002,48(8),1160-1169","journal-title":"Clin Chem"},{"key":"ref=67","author":"Diamandis E.P.","year":"2002","unstructured":"Diamandis E.P.; Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications 2002","journal-title":"Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1164\/ajrccm\/144.3_pt_2.S42","volume":"144","author":"Gendler S.J.","year":"1991","unstructured":"Gendler S.J.; Spicer A.P.; Lalani E.N.; Duhig T.; Peat N.; Burchell J.; Pemberton L.; Boshell M.; Taylor-Papadimitriou J.; Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis 1991,144(3 Pt 2),S42-S47","journal-title":"Am Rev Respir Dis"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0960-9776(98)9010-9","volume":"7","author":"Graves R.","year":"1998","unstructured":"Graves R.; Hilgers J.; Fritsche H.; Hayes D.; Robertson J.F.R.; MUC-1 mucin assays for monitoring therapy in metastatic breast cancer. Breast 1998,7(4),181-186","journal-title":"Breast"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.2147\/IJN.S127086","volume":"12","author":"Mouffouk F.","year":"2017","unstructured":"Mouffouk F.; Aouabdi S.; Al-Hetlani E.; Serrai H.; Alrefae T.; Leo Chen L.; New generation of electrochemical immunoassay based on polymeric nanoparticles for early detection of breast cancer. Int J Nanomedicine 2017,12,3037-3047","journal-title":"Int J Nanomedicine"},{"key":"ref=71","first-page":"6365","volume":"52","author":"Perey L.","year":"1992","unstructured":"Perey L.; Hayes D.F.; Kufe D.; Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope. Cancer Res 1992,52(22),6365-6370","journal-title":"Cancer Res"},{"key":"ref=72","first-page":"2563","volume":"52","author":"Perey L.","year":"1992","unstructured":"Perey L.; Hayes D.F.; Maimonis P.; Abe M.; O\u2019Hara C.; Kufe D.W.; Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res 1992,52(9),2563-2568","journal-title":"Cancer Res"},{"key":"ref=73","first-page":"4061","volume":"61","author":"Akewanlop C.","year":"2001","unstructured":"Akewanlop C.; Watanabe M.; Singh B.; Walker M.; Kufe D.W.; Hayes D.F.; Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody. Cancer Res 2001,61(10),4061-4065","journal-title":"Cancer Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbcan.2011.01.001","volume":"1815","author":"Mukhopadhyay P.","year":"2011","unstructured":"Mukhopadhyay P.; Chakraborty S.; Ponnusamy M.P.; Lakshmanan I.; Jain M.; Batra S.K.; Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochim Biophys Acta 2011,1815(2),224-240","journal-title":"Biochim Biophys Acta"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13058-017-0827-4","volume":"19","author":"Cordone I.","year":"2017","unstructured":"Cordone I.; Masi S.; Summa V.; Carosi M.; Vidiri A.; Fabi A.; Pasquale A.; Conti L.; Rosito I.; Carapella C.M.; Villani V.; Pace A.; Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study. Breast Cancer Res 2017,19(1),46","journal-title":"Breast Cancer Res"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1200\/JCO.1991.9.7.1113","volume":"9","author":"Hayes D.F.","year":"1991","unstructured":"Hayes D.F.; Mesa-Tejada R.; Papsidero L.D.; Croghan G.A.; Korzun A.H.; Norton L.; Wood W.; Strauchen J.A.; Grimes M.; Weiss R.B.; Ree H.; Thor A.; Koerner F.; Rice M.; Barcos M.; Kufe D.W.; Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36\/22, and CU18: a Cancer and Leukemia Group B study. J Clin Oncol 1991,9(7),1113-1123","journal-title":"J Clin Oncol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF01806021","volume":"5","author":"Lundy J.","year":"1985","unstructured":"Lundy J.; Thor A.; Maenza R.; Schlom J.; Forouhar F.; Testa M.; Kufe D.; Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients. Breast Cancer Res Treat 1985,5(3),269-276","journal-title":"Breast Cancer Res Treat"},{"key":"ref=78","first-page":"2834","volume":"49","author":"Abe M.","year":"1989","unstructured":"Abe M.; Kufe D.; Structural analysis of the DF3 human breast carcinoma-associated protein. Cancer Res 1989,49(11),2834-2839","journal-title":"Cancer Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10549-018-4989-2","volume":"173","author":"Astashchanka A.","year":"2019","unstructured":"Astashchanka A.; Shroka T.M.; Jacobsen B.M.; Mucin 2 (MUC2) modulates the aggressiveness of breast cancer. Breast Cancer Res Treat 2019,173(2),289-299","journal-title":"Breast Cancer Res Treat"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3389\/fonc.2020.00964","volume":"10","author":"Bahl A.","year":"2020","unstructured":"Bahl A.; Talwar V.; Sirohi B.; Mehta P.; Arya D.; Shrivastava G.; Dahiya A.; Pavithran K.; Primary tumor location as a prognostic and predictive marker in metastatic colorectal cancer (mCRC). Front Oncol 2020,10,964","journal-title":"Front Oncol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2391670","DOI":"10.1155\/2019\/2391670","volume":"2019","author":"Li C.","year":"2019","unstructured":"Li C.; Zuo D.; Liu T.; Yin L.; Li C.; Wang L.; Prognostic and clinicopathological significance of muc family members in colorectal cancer: a systematic review and meta-analysis. Gastroenterol Res Pract 2019,2019,2391670","journal-title":"Gastroenterol Res Pract"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/cancers12030649","volume":"12","author":"Pothuraju R.","year":"2020","unstructured":"Pothuraju R.; Krishn S.R.; Gautam S.K.; Pai P.; Ganguly K.; Chaudhary S.; Rachagani S.; Kaur S.; Batra S.K.; Mechanistic and functional shades of mucins and associated glycans in colon cancer. Cancer 2020,12(3),649","journal-title":"Cancer"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000051917","volume":"63","author":"Hayashi T.","year":"2001","unstructured":"Hayashi T.; Takahashi T.; Motoya S.; Ishida T.; Itoh F.; Adachi M.; Hinoda Y.; Imai K.; MUC1 mucin core protein binds to the domain 1 of ICAM-1. Digestion 2001,63(1)(Suppl. 1),87-92","journal-title":"Digestion"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","volume":"20","author":"Nath S.","year":"2014","unstructured":"Nath S.; Mukherjee P.; MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med 2014,20(6),332-342","journal-title":"Trends Mol Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4161\/gmic.1.1.10470","volume":"1","author":"Hansson G.C.","year":"2010","unstructured":"Hansson G.C.; Johansson M.E.; The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Gut Microbes 2010,1(1),51-54","journal-title":"Gut Microbes"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ijc.1460","volume":"94","author":"Tsukashita S.","year":"2001","unstructured":"Tsukashita S.; Kushima R.; Bamba M.; Sugihara H.; Hattori T.; MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer 2001,94(2),166-170","journal-title":"Int J Cancer"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"15519","DOI":"10.4172\/2161-069X.1000123","volume":"3","author":"Boltin D.","year":"2013","unstructured":"Boltin D.; Niv Y.; Mucins in Gastric Cancer - An Update. J Gastrointest Dig Syst 2013,3(123),15519","journal-title":"J Gastrointest Dig Syst"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/ijms21114012","volume":"21","author":"Machlowska J.","year":"2020","unstructured":"Machlowska J.; Baj J.; Sitarz M.; Maciejewski R.; Sitarz R.; Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci 2020,21(11),4012","journal-title":"Int J Mol Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41374-019-0293-y","volume":"99","author":"Muthupalani S.","year":"2019","unstructured":"Muthupalani S.; Ge Z.; Joy J.; Feng Y.; Dobey C.; Cho H-Y.; Langenbach R.; Wang T.C.; Hagen S.J.; Fox J.G.; Muc5ac null mice are predisposed to spontaneous gastric antro-pyloric hyperplasia and adenomas coupled with attenuated H. pylori-induced corpus mucous metaplasia. Lab Invest 2019,99(12),1887-1905","journal-title":"Lab Invest"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.3748\/wjg.v16.i37.4634","volume":"16","author":"Namikawa T.","year":"2010","unstructured":"Namikawa T.; Hanazaki K.; Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma. World J Gastroenterol 2010,16(37),4634-4639","journal-title":"World J Gastroenterol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.14670\/HH-23.1541","volume":"23","author":"Senapati S.","year":"2008","unstructured":"Senapati S.; Sharma P.; Bafna S.; Roy H.K.; Batra S.K.; The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histol Histopathol 2008,23(12),1541-1552","journal-title":"Histol Histopathol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/jcp.56.5.378","volume":"56","author":"Wang R.Q.","year":"2003","unstructured":"Wang R.Q.; Fang D.C.; Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features. J Clin Pathol 2003,56(5),378-384","journal-title":"J Clin Pathol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s10120-019-00932-0","volume":"22","author":"Lin S.","year":"2019","unstructured":"Lin S.; Zhang Y.; Hu Y.; Yang B.; Cui J.; Huang J.; Wang J.M.; Xing R.; Lu Y.; Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-&#x3BA;B-mediated expression of CEACAM1-3S in human gastric cancer. Gastric Cancer 2019,22(5),941-954","journal-title":"Gastric Cancer"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2407-5-124","volume":"5","author":"Hebbar V.","year":"2005","unstructured":"Hebbar V.; Damera G.; Sachdev G.P.; Differential expression of MUC genes in endometrial and cervical tissues and tumors. BMC Cancer 2005,5,124","journal-title":"BMC Cancer"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1210\/endo.136.8.7628404","volume":"136","author":"Surveyor G.A.","year":"1995","unstructured":"Surveyor G.A.; Gendler S.J.; Pemberton L.; Das S.K.; Chakraborty I.; Julian J.; Pimental R.A.; Wegner C.C.; Dey S.K.; Carson D.D.; Expression and steroid hormonal control of Muc-1 in the mouse uterus. Endocrinology 1995,136(8),3639-3647","journal-title":"Endocrinology"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1600-0897.1996.tb00042.x","volume":"35","author":"Aplin J.D.","year":"1996","unstructured":"Aplin J.D.; Hey N.A.; Li T.C.; MUC1 as a cell surface and secretory component of endometrial epithelium: reduced levels in recurrent miscarriage. Am J Reprod Immunol 1996,35(3),261-266","journal-title":"Am J Reprod Immunol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3390\/cells9051188","volume":"9","author":"Hebeda C.B.","year":"2020","unstructured":"Hebeda C.B.; Sandri S.; Benis C.M.; Paula-Silva M.; Loiola R.A.; Reutelingsperger C.; Perretti M.; Farsky S.H.P.; Annexin a1\/formyl peptide receptor pathway controls uterine receptivity to the blastocyst. Cells 2020,9(5),1188","journal-title":"Cells"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/s0015-0282(16)58460-x","volume":"66","author":"D\u2019Cruz O.J.","year":"1996","unstructured":"D\u2019Cruz O.J.; Dunn T.S.; Pichan P.; Hass G.G.; Sachdev G.P.; Antigenic cross-reactivity of human tracheal mucin with human sperm and trophoblasts correlates with the expression of mucin 8 gene messenger ribonucleic acid in reproductive tract tissues. Fertil Steril 1996,66(2),316-326","journal-title":"Fertil Steril"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.3390\/ijms21134569","volume":"21","author":"Wadowska K.","year":"2020","unstructured":"Wadowska K.; Bil-Lula I.; Trembecki \u0141.; &#x15A;liwi\u0144ska-Mosso\u0144 M.; Genetic markers in lung cancer diagnosis: a review. Int J Mol Sci 2020,21(13),4569","journal-title":"Int J Mol Sci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcdb.2016.08.027","volume":"64","author":"Xu M.","year":"2017","unstructured":"Xu M.; Wang D.C.; Wang X.; Zhang Y.; Correlation between mucin biology and tumor heterogeneity in lung cancer. Semin Cell Dev Biol 2017,64,73-78","journal-title":"Semin Cell Dev Biol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1182\/blood-2008-08-077941","volume":"112","author":"Dick J.E.","year":"2008","unstructured":"Dick J.E.; Stem cell concepts renew cancer research. Blood 2008,112(13),4793-4807","journal-title":"Blood"},{"key":"ref=102","first-page":"10365","volume":"8","author":"Li P.","year":"2015","unstructured":"Li P.; Xiao L.Y.; Tan H.; Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling. Int J Clin Exp Pathol 2015,8(9),10365-10374","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"BSR20182193","DOI":"10.1042\/BSR20182193","volume":"39","author":"Zhang A.M.","year":"2019","unstructured":"Zhang A.M.; Chi X.H.; Bo Z.Q.; Huang X.F.; Zhang J.; MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells. Biosci Rep 2019,39(9),BSR20182193","journal-title":"Biosci Rep"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.ijbiomac.2019.01.009","volume":"126","author":"Jafari M.","year":"2019","unstructured":"Jafari M.; Hasanzadeh M.; Solhi E.; Hassanpour S.; Shadjou N.; Mokhtarzadeh A.; Jouyban A.; Mahboob S.; Ultrasensitive bioassay of epitope of Mucin-16 protein (CA 125) in human plasma samples using a novel immunoassay based on silver conductive nano-ink: A new platform in early stage diagnosis of ovarian cancer and efficient management. Int J Biol Macromol 2019,126,1255-1265","journal-title":"Int J Biol Macromol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2015.11.025","volume":"140","author":"Chen C.H.","year":"2016","unstructured":"Chen C.H.; Shyu M.K.; Wang S.W.; Chou C.H.; Huang M.J.; Lin T.C.; Chen S.T.; Lin H.H.; Huang M.C.; MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin &#x3B2;1 pathway. Gynecol Oncol 2016,140(1),131-137","journal-title":"Gynecol Oncol"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.1840200514","volume":"20","author":"Sasaki M.","year":"1994","unstructured":"Sasaki M.; Nakanuma Y.; Expression of mucin core protein of mammary type in primary liver cancer. Hepatology 1994,20(5),1192-1197","journal-title":"Hepatology"},{"key":"ref=107","first-page":"647","volume":"25","author":"Allen R.A.","year":"1949","unstructured":"Allen R.A.; Lisa J.R.; Combined liver cell and bile duct carcinoma. Am J Pathol 1949,25(4),647-655","journal-title":"Am J Pathol"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.livres.2017.12.005","volume":"1","author":"Liang K-H.","year":"2017","unstructured":"Liang K-H.; Yeh C-T.; O-glycosylation in liver cancer: Clinical associations and potential mechanisms. Liver Res 2017,1,193-196","journal-title":"Liver Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3748\/wjg.v11.i30.4661","volume":"11","author":"Yuan S.F.","year":"2005","unstructured":"Yuan S.F.; Li K.Z.; Wang L.; Dou K.F.; Yan Z.; Han W.; Zhang Y.Q.; Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue. World J Gastroenterol 2005,11(30),4661-4666","journal-title":"World J Gastroenterol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"e0157878","DOI":"10.1371\/journal.pone.0157878","volume":"11","author":"Li B.","year":"2016","unstructured":"Li B.; Tang H.; Zhang A.; Dong J.; Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis. PLoS One 2016,11(6),e0157878","journal-title":"PLoS One"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel R.L.","year":"2019","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2019. CA Cancer J Clin 2019,69(1),7-34","journal-title":"CA Cancer J Clin"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1038\/onc.2014.409","volume":"34","author":"Kumar S.","year":"2015","unstructured":"Kumar S.; Das S.; Rachagani S.; Kaur S.; Joshi S.; Johansson S.L.; Ponnusamy M.P.; Jain M.; Batra S.K.; NCOA3-mediated upregulation of mucin expression via transcriptional and post- translational changes during the development of pancreatic cancer. Oncogene 2015,34(37),4879-4889","journal-title":"Oncogene"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1440-1827.1998.tb03913.x","volume":"48","author":"Yonezawa S.","year":"1998","unstructured":"Yonezawa S.; Taira M.; Osako M.; Kubo M.; Tanaka S.; Sakoda K.; Takao S.; Aiko T.; Yamamoto M.; Irimura T.; Kim Y.S.; Sato E.; MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int 1998,48(4),319-322","journal-title":"Pathol Int"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1476-4598-2-9","volume":"2","author":"Ringel J.","year":"2003","unstructured":"Ringel J.; L&#xF6;hr M.; The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol Cancer 2003,2,9","journal-title":"Mol Cancer"},{"key":"ref=115","first-page":"1372","volume":"7","author":"Suh H.","year":"2017","unstructured":"Suh H.; Pillai K.; Morris D.L.; Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy. Am J Cancer Res 2017,7(6),1372-1383","journal-title":"Am J Cancer Res"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.151.2.767","volume":"151","year":"1993","unstructured":"Van, de.Wiel-van.Kemenade. E.;Ligtenberg, M. J.; de, Boer. A. J.; Buijis, F.; Vos, H. L.; Melief, C. J.; Hilkens, J.; Figdor, C. G. Episialin (MUC1) inhibits cytotoxic lymphocytetarget cell interaction. J Immunol 1993,151(2),767-776","journal-title":"J Immunol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1083\/jcb.129.1.255","volume":"129","author":"Wesseling J.","year":"1995","unstructured":"Wesseling J.; Van, Der.Valk. S. W.;Vos, H. L.;Sonnenberg, A.; Hilkens, J.Episialin (MUCl) over-expression inhibits integrin-mediated cell adhesion to extracellular matrix component. J Cell Biol 1995,129(1),255-265","journal-title":"J Cell Biol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1177\/41.10.8245407","volume":"41","author":"Audie J.P.","year":"1993","unstructured":"Audie J.P.; Janin A.; Porchet N.; Copin M.C.; Gosselin B.; Aubert J.P.; Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J Histochem Cytochem 1993,41(10),1479-1485","journal-title":"J Histochem Cytochem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/humrep\/10.1.98","volume":"10","author":"Audie J.P.","year":"1995","unstructured":"Audie J.P.; Tetaert D.; Pigny P.; Buisine M.P.; Janin A.; Aubert J.P.; Porchet N.; Boersma A.; Mucin gene expression in the human endocervix. Hum Reprod 1995,10(1),98-102","journal-title":"Hum Reprod"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/gut.43.4.519","volume":"43","author":"Buisine M.P.","year":"1998","unstructured":"Buisine M.P.; Devisme L.; Savidge T.C.; Gespach C.; Gosselin B.; Porchet N.; Aubert J.P.; Mucin gene expression in human embryonic and fetal intestine. Gut 1998,43(4),519-524","journal-title":"Gut"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1165\/ajrcmb.20.2.3259","volume":"20","author":"Buisine M.P.","year":"1999","unstructured":"Buisine M.P.; Devisme L.; Copin M.C.; Durand-R&#xE9;ville M.; Gosselin B.; Aubert J.P.; Porchet N.; Developmental mucin gene expression in the human respiratory tract. Am J Respir Cell Mol Biol 1999,20(2),209-218","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/0006-291x(91)91580-6","volume":"175","author":"Porchet N.","year":"1991","unstructured":"Porchet N.; Nguyen V.C.; Dufosse J.; Audie J.P.; Guyonnet-Duperat V.; Gross M.S.; Denis C.; Degand P.; Bernheim A.; Aubert J.P.; Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Commun 1991,175(2),414-422","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bjc.6603868","volume":"97","author":"Moniaux N.","year":"2007","unstructured":"Moniaux N.; Chaturvedi P.; Varshney G.C.; Meza J.L.; Rodriguez-Sierra J.F.; Aubert J.P.; Batra S.K.; Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. Br J Cancer 2007,97(3),345-357","journal-title":"Br J Cancer"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/oxfordjournals.jbchem.a003073","volume":"131","author":"Khorrami A.M.","year":"2002","unstructured":"Khorrami A.M.; Choudhury A.; Andrianifahanana M.; Varshney G.C.; Bhattacharyya S.N.; Hollingsworth M.A.; Kaufman B.; Batra S.K.; Purification and characterization of a human pancreatic adenocarcinoma mucin. J Biochem 2002,131(1),21-29","journal-title":"J Biochem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3109\/00365521.2013.832368","volume":"48","author":"Ansari D.","year":"2013","unstructured":"Ansari D.; Urey C.; Gundewar C.; Bauden M.P.; Andersson R.; Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases. Scand J Gastroenterol 2013,48(10),1183-1187","journal-title":"Scand J Gastroenterol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/carcin\/bgs225","volume":"33","author":"Rachagani S.","year":"2012","unstructured":"Rachagani S.; Macha M.A.; Ponnusamy M.P.; Haridas D.; Kaur S.; Jain M.; Batra S.K.; MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis 2012,33(10),1953-1964","journal-title":"Carcinogenesis"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3892\/ijo.2015.3316","volume":"48","author":"Liu L.","year":"2016","unstructured":"Liu L.; Xiang J.; Chen R.; Fu D.; Hong D.; Hao J.; Li Y.; Li J.; Li S.; Mou Y.; Mai G.; Ni Q.; Peng L.; Qin R.; Qian H.; Shao C.; Sun B.; Sun Y.; Tao M.; Tian B.; Wang H.; Wang J.; Wang L.; Wang W.; Wang W.; Zhang J.; Zhao G.; Zhou J.; Yu X.; The clinical utility of CA125\/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC). Int J Oncol Chinese Study Group for Pancreatic Cancer (CSPAC)2016,48(3),900-907","journal-title":"Int J Oncol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3892\/mco.2013.226","volume":"2","author":"Wang Z.","year":"2014","unstructured":"Wang Z.; Tian Y.P.; Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma. Mol Clin Oncol 2014,2(2),265-268","journal-title":"Mol Clin Oncol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1756-8722-5-68","volume":"5","author":"Rachagani S.","year":"2012","unstructured":"Rachagani S.; Torres M.P.; Kumar S.; Haridas D.; Baine M.; Macha M.A.; Kaur S.; Ponnusamy M.P.; Dey P.; Seshacharyulu P.; Johansson S.L.; Jain M.; Wagner K.U.; Batra S.K.; Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. J Hematol Oncol 2012,5,68","journal-title":"J Hematol Oncol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/1097-0142(19900401)65:7<1557:aid-cncr2820650718>3.0.co;2-w","volume":"65","author":"Kiriyama S.","year":"1990","unstructured":"Kiriyama S.; Hayakawa T.; Kondo T.; Shibata T.; Kitagawa M.; Ono H.; Sakai Y.; Usefulness of a new tumor marker, Span-1, for the diagnosis of pancreatic cancer. Cancer 1990,65(7),1557-1561","journal-title":"Cancer"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"9665","DOI":"10.1038\/s41598-019-46046-6","volume":"9","author":"Leiphrakpam P.D.","year":"2019","unstructured":"Leiphrakpam P.D.; Patil P.P.; Remmers N.; Swanson B.; Grandgenett P.M.; Qiu F.; Yu F.; Radhakrishnan P.; Role of keratan sulfate expression in human pancreatic cancer malignancy. Sci Rep 2019,9(1),9665","journal-title":"Sci Rep"},{"key":"ref=132","first-page":"601","volume":"42","author":"Metzgar R.S.","year":"1982","unstructured":"Metzgar R.S.; Gaillard M.T.; Levine S.J.; Tuck F.L.; Bossen E.H.; Borowitz M.J.; Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res 1982,42(2),601-608","journal-title":"Cancer Res"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/pcan.2016.11","volume":"19","author":"Genitsch V.","year":"2016","unstructured":"Genitsch V.; Zlobec I.; Thalmann G.N.; Fleischmann A.; MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor. Prostate Cancer Prostatic Dis 2016,19(3),242-247","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41467-019-14219-6","volume":"11","author":"Yasumizu Y.","year":"2020","unstructured":"Yasumizu Y.; Rajabi H.; Jin C.; Hata T.; Pitroda S.; Long M.D.; Hagiwara M.; Li W.; Hu Q.; Liu S.; Yamashita N.; Fushimi A.; Kui L.; Samur M.; Yamamoto M.; Zhang Y.; Zhang N.; Hong D.; Maeda T.; Kosaka T.; Wong K.K.; Oya M.; Kufe D.; MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun 2020,11(1),338","journal-title":"Nat Commun"},{"key":"ref=135","first-page":"2213","volume":"9","author":"Rassidakis G.Z.","year":"2003","unstructured":"Rassidakis G.Z.; Goy A.; Medeiros L.J.; Jiang Y.; Thomaides A.; Remache Y.; Cabanillas F.; Sarris A.H.; Gilles F.; Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma. Clin Cancer Res 2003,9(6),2213-2220","journal-title":"Clin Cancer Res"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"583","DOI":"10.7150\/jca.11567","volume":"6","author":"Mocan T.","year":"2015","unstructured":"Mocan T.; Matea C.; Tabaran F.; Iancu C.; Orasan R.; Mocan L.; In Vitro administration of gold nanoparticles functionalized with muc-1 protein fragment generates anticancer vaccine response via macrophage activation and polarization mechanism. J Cancer 2015,6(6),583-592","journal-title":"J Cancer"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1083\/jcb.129.1.255","volume":"129","author":"Wesseling J.","year":"1995","unstructured":"Wesseling J.; van der Valk S.W.; Vos H.L.; Sonnenberg A.; Hilkens J.; Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995,129(1),255-265","journal-title":"J Cell Biol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/biom6040039","volume":"6","author":"Cascio S.","year":"2016","unstructured":"Cascio S.; Finn O.J.; Intra- and extra-cellular events related to altered glycosylation of muc1 promote chronic inflammation, tumor progression, invasion, and metastasis. Biomolecules 2016,6(4),39","journal-title":"Biomolecules"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"67152","DOI":"10.18632\/oncotarget.17934","volume":"8","author":"King R.J.","year":"2017","unstructured":"King R.J.; Yu F.; Singh P.K.; Genomic alterations in mucins across cancers. Oncotarget 2017,8(40),67152-67168","journal-title":"Oncotarget"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13046-020-01662-3","volume":"39","author":"Ning Y.","year":"2020","unstructured":"Ning Y.; Zheng H.; Zhan Y.; Liu S.; Yang Y.; Zang H.; Luo J.; Wen Q.; Fan S.; Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer. J Exp Clin Cancer Res 2020,39(1),162","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1038\/oncsis.2015.47","volume":"5","author":"Ham S.Y.","year":"2016","unstructured":"Ham S.Y.; Kwon T.; Bak Y.; Yu J.H.; Hong J.; Lee S.K.; Yu D.Y.; Yoon D.Y.; Mucin 1-mediated chemo-resistance in lung cancer cells. Oncogenesis 2016,5(1),e185","journal-title":"Oncogenesis"},{"key":"ref=142","first-page":"219","volume":"5","author":"Giannakouros P.","year":"2014","unstructured":"Giannakouros P.; Comamala M.; Matte I.; Rancourt C.; Pich&#xE9; A.; MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering &#x3B2;-catenin signaling. Am J Cancer Res 2014,5(1),219-230","journal-title":"Am J Cancer Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s13277-013-1178-0","volume":"35","author":"Gao L.","year":"2014","unstructured":"Gao L.; Liu J.; Zhang B.; Zhang H.; Wang D.; Zhang T.; Liu Y.; Wang C.; Functional MUC4 suppress epithelial-mesenchymal transition in lung adenocarcinoma metastasis. Tumour Biol 2014,35(2),1335-1341","journal-title":"Tumour Biol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/carcin\/bgw005","volume":"37","author":"Pai P.","year":"2016","unstructured":"Pai P.; Rachagani S.; Dhawan P.; Batra S.K.; Mucins and Wnt\/&#x3B2;-catenin signaling in gastrointestinal cancers: an unholy nexus. Carcinogenesis 2016,37(3),223-232","journal-title":"Carcinogenesis"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molonc.2015.10.005","volume":"10","author":"Pai P.","year":"2016","unstructured":"Pai P.; Rachagani S.; Lakshmanan I.; Macha M.A.; Sheinin Y.; Smith L.M.; Ponnusamy M.P.; Batra S.K.; The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Mol Oncol 2016,10(2),224-239","journal-title":"Mol Oncol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1038\/oncsis.2014.19","volume":"3","author":"Liu X.","year":"2014","unstructured":"Liu X.; Caffrey T.C.; Steele M.M.; Mohr A.; Singh P.K.; Radhakrishnan P.; Kelly D.L.; Wen Y.; Hollingsworth M.A.; MUC1 regulates cyclin D1 gene expression through p120 catenin and &#x3B2;- catenin. Oncogenesis 2014,3(6),e107","journal-title":"Oncogenesis"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"26125","DOI":"10.1074\/jbc.M115.651489","volume":"290","author":"Mori Y.","year":"2015","unstructured":"Mori Y.; Akita K.; Yashiro M.; Sawada T.; Hirakawa K.; Murata T.; Nakada H.; Binding of galectin-3, a &#x3B2;-galactoside-binding lectin, to MUC1 protein enhances phosphorylation of extracellular signal-regulated kinase 1\/2 (ERK1\/2) and Akt, promoting tumour cell malignancy. J Biol Chem 2015,290(43),26125-26140","journal-title":"J Biol Chem"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.18632\/oncotarget.3045","volume":"6","author":"Chou C.H.","year":"2015","unstructured":"Chou C.H.; Huang M.J.; Chen C.H.; Shyu M.K.; Huang J.; Hung J.S.; Huang C.S.; Huang M.C.; Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway. Oncotarget 2015,6(8),6123-6135","journal-title":"Oncotarget"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11523-016-0446-5","volume":"11","author":"Wang J.","year":"2016","unstructured":"Wang J.; Tai G.; Role of C-Jun N-terminal Kinase in hepatocellular carcinoma development. Target Oncol 2016,11(6),723-738","journal-title":"Target Oncol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/cas.13144","volume":"108","author":"Wang J.","year":"2017","unstructured":"Wang J.; Ni W.H.; Hu K.B.; Zhai X.Y.; Xie F.; Jie J.; Zhang N.N.; Jiang L.N.; Yuan H.Y.; Tai G.X.; Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma. Cancer Sci 2017,108(3),504-511","journal-title":"Cancer Sci"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1042\/BST20170400","volume":"46","author":"Taylor-Papadimitriou J.","year":"2018","unstructured":"Taylor-Papadimitriou J.; Burchell J.M.; Graham R.; Beatson R.; Latest developments in MUC1 immunotherapy. Biochem Soc Trans 2018,46(3),659-668","journal-title":"Biochem Soc Trans"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/onc.2016.241","volume":"36","author":"Sheng Y.H.","year":"2017","unstructured":"Sheng Y.H.; He Y.; Hasnain S.Z.; Wang R.; Tong H.; Clarke D.T.; Lourie R.; Oancea I.; Wong K.Y.; Lumley J.W.; Florin T.H.; Sutton P.; Hooper J.D.; McMillan N.A.; McGuckin M.A.; MUC13 protects colorectal cancer cells from death by activating the NF-&#x3BA;B pathway and is a potential therapeutic target. Oncogene 2017,36(5),700-713","journal-title":"Oncogene"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/cancers9110155","volume":"9","author":"Zamay T.N.","year":"2017","unstructured":"Zamay T.N.; Zamay G.S.; Kolovskaya O.S.; Zukov R.A.; Petrova M.M.; Gargaun A.; Berezovski M.V.; Kichkailo A.S.; Current and prospective protein biomarkers of lung cancer. Cancers (Basel) 2017,9(11),155","journal-title":"Cancers (Basel)"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1007\/s13277-015-3479-y","volume":"36","author":"Sahlin M.","year":"2015","unstructured":"Sahlin M.; Bauden M.P.; Andersson R.; Ansari D.; Radioimmunotherapy- a potential novel tool for pancreatic cancer therapy? Tumour Biol 2015,36(6),4053-4062","journal-title":"Tumour Biol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"E2004","DOI":"10.3390\/ijms19072004","volume":"19","author":"Wu G.","year":"2018","unstructured":"Wu G.; Maharjan S.; Kim D.; Kim J.N.; Park B.K.; Koh H.; Moon K.; Lee Y.; Kwon H.J.; A novel monoclonal antibody targets Mucin1 and attenuates growth in pancreatic cancer model. Int J Mol Sci 2018,19(7),E2004","journal-title":"Int J Mol Sci"},{"key":"ref=156","author":"Kufe D.W.","year":"2014","unstructured":"Kufe D.W.; Kharbanda S.; Combination anti-her2 cancer therapy using mucl peptides and chemotherapeutics. 2014"},{"key":"ref=157","author":"Nakano K.","year":"2013","unstructured":"Nakano K.; Combination anti- her2 cancer therapy using mucl peptides and chemotherapeutics. 2013"},{"key":"ref=158","author":"Denardo S.J.","year":"2007","unstructured":"Denardo S.J.; Winthrop M.D.; Denardo G.L.; Xiong C.; Anti- muc-1 single-chain antibodies for tumour targeting. 2007"},{"key":"ref=159","author":"Schlom J.","year":"2016","unstructured":"Schlom J.; Schlom K.; Humancytotoxict-lymphocyte epitope and its against epitope from a thenon-variable number of tandem repeat sequence of muc-1. 2016"},{"key":"ref=160","author":"Longenecker B.M.","year":"2015","unstructured":"Longenecker B.M.; Method of treating patients with a mucinous glycoprotein (muc-1) vaccine. 2015"},{"key":"ref=161","author":"Kufe D.W.","year":"2018","unstructured":"Kufe D.W.; Kharbanda S.; Antibodies against the muc1 - c \/ extracellular domain ( muc1-c\/ecd). 2018"},{"key":"ref=162","author":"Franzusov A.","year":"2019","unstructured":"Franzusov A.; Zhimin G.; Schlom J.; Sang K-Y.; Yeast-MUC1 immunotherapeutic composition and application thereof. 2019"},{"key":"ref=163","author":"Coupe D.W.","year":"2016","unstructured":"Coupe D.W.; Calvanda S.; MUC-1 cytoplasmic domain peptide as an inhibitor of cancer. 2016"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-020-01151-3","volume":"19","author":"Fan J.Q.","year":"2020","unstructured":"Fan J.Q.; Wang M.F.; Chen H.L.; Shang D.; Das J.K.; Song J.; Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma. Mol Cancer 2020,19(1),32","journal-title":"Mol Cancer"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1158\/1535-7163.MCT-09-0646","volume":"8","author":"Joshi M.D.","year":"2009","unstructured":"Joshi M.D.; Ahmad R.; Yin L.; Raina D.; Rajabi H.; Bubley G.; Kharbanda S.; Kufe D.; MUC1 oncoprotein is a druggable target in human prostate cancer cells. Mol Cancer Ther 2009,8(11),3056-3065","journal-title":"Mol Cancer Ther"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1158\/0008-5472.CAN-09-0854","volume":"69","author":"Raina D.","year":"2009","unstructured":"Raina D.; Ahmad R.; Joshi M.D.; Yin L.; Wu Z.; Kawano T.; Vasir B.; Avigan D.; Kharbanda S.; Kufe D.; Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res 2009,69(12),5133-5141","journal-title":"Cancer Res"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"s4652","DOI":"10.1158\/1078-0432.CCR-07-0213","volume":"13","author":"Sangha R.","year":"2007","unstructured":"Sangha R.; Butts C.; L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clin Cancer Res 2007,13(15 Pt 2),s4652-s4654","journal-title":"Clin Cancer Res"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/jamaoncol.2015.2736","volume":"1","author":"Heery C.R.","year":"2015","unstructured":"Heery C.R.; Ibrahim N.K.; Arlen P.M.; Mohebtash M.; Murray J.L.; Koenig K.; Madan R.A.; McMahon S.; Mart&#xE9; J.L.; Steinberg S.M.; Donahue R.N.; Grenga I.; Jochems C.; Farsaci B.; Folio L.R.; Schlom J.; Gulley J.L.; Ibrahim N.K.; Arlen, P.M.; Mohebtash, M.; Murray, J.L.; Koenig, K.; Madan, R.A.; McMahon, S.; Mart&#xE9;, J.L.; Steinberg, S.M.; Donahue, R.N.; Grenga, I.; Jochems, C.; Farsaci, B.; Folio, L.R.; Schlom, J.; GulleyeJ.L.Docetaxel alone or in combination with a therapeutic cancer vaccine (PANVAC) in patients with metastatic breast cancer: a randomized clinical trial. JAMA Oncol 2015,1(8),1087-1095","journal-title":"JAMA Oncol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1200\/JCO.2008.17.8400","volume":"27","author":"Berek J.","year":"2009","unstructured":"Berek J.; Taylor P.; McGuire W.; Smith L.M.; Schultes B.; Nicodemus C.F.; Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced ovarian cancer. J Clin Oncol 2009,27(3),418-425","journal-title":"J Clin Oncol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1476-4598-13-129","volume":"13","author":"Felder M.","year":"2014","unstructured":"Felder M.; Kapur A.; Gonzalez-Bosquet J.; Horibata S.; Heintz J.; Albrecht R.; Fass L.; Kaur J.; Hu K.; Shojaei H.; Whelan R.J.; Patankar M.S.; MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress. Mol Cancer 2014,13,129","journal-title":"Mol Cancer"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/188005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/188005\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/188005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T10:02:47Z","timestamp":1697104967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/188005\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":170,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009620666201116113334","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}